Moody’s has also affirmed the “A2” rating on Highland’s outstanding rated debt.
The rating assignment is based on a number of factors, including Highland’s healthy financial performance and the expectation that the new bond-financed facilities will be well utilized and generate additional cash flow.
The rating outlook is stable, reflecting Moody’s expectation that Highland will continue to generate good operating cash flow and that the hospital has no additional borrowing plans over the next two years.
More articles on finance:
Private equity firm Thoma Bravo to acquire majority stake in MedeAnalytics
RCM tip of the day: Automate & monitor metrics that matter
Why HCA is taking the road less traveled when it comes to expansion
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
